Back to News
Market Impact: 0.2
Wall Street Analysts See a 35.71% Upside in Assembly Biosciences (ASMB): Can the Stock Really Move This High?
Source: zacks.com
Analyst EstimatesAnalyst InsightsHealthcare & Biotech
Wall Street analysts' average price target for Assembly Biosciences implies 35.7% upside. The article cautions that price-target averages may be unreliable, but notes that favorable earnings-estimate revisions could support further gains in ASMB shares.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
ASMB0.38
More News
- Citizens raises Enova stock price target on strong growth outlook
- Citizens raises Union Pacific stock price target on merger progress
- Citizens reiterates Lazard stock rating citing strong forward indicators
- Rosenblatt raises Meta stock price target to $900 on AI ad growth
- Why is Lancashire stock sliding today?
- Moderna shares plunge after leak of partial cancer vaccine data